Clinical Trial Update: Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial [Phase 3]

View source ↗

Summary

Phase 3 trial to evaluate milrinone for preventing post-ligation cardiac syndrome in neonates; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ligation Cardiac Syndrome

Drugs mentioned

• Milrinone (milrinone)
• Primacor (Milrinone)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Post-ligation Cardiac Syndrome | Phase 3 | Status: RECRUITING